What's in Melinta Therapeutics, Inc.'s pipeline?

Melinta Therapeutics, Inc. has 4 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Melinta Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Durata Therapeutics Inc., an affiliate of Allergan plc, Ironshore Pharmaceuticals and Development, Inc, Jiangsu HengRui Medicine Co., Ltd., University of Colorado, Denver.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/melinta-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Melinta Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Melinta Therapeutics, Inc. pipeline: 1 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Kimyrsa	Kimyrsa	marketed			Other
Single-Dose IV Oritavancin Diphosphate	Single-Dose IV Oritavancin Diphosphate	phase 3	Lipoglycopeptide antibiotic	Lipid II	Infectious Diseases

Therapeutic area mix

Infectious Diseases · 1
Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Durata Therapeutics Inc., an affiliate of Allergan plc · 1 shared drug class
Ironshore Pharmaceuticals and Development, Inc · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
University of Colorado, Denver · 1 shared drug class
University of Pennsylvania · 1 shared drug class
Veradermics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Melinta Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Melinta Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/melinta-therapeutics-inc. Accessed 2026-05-16.